Data resulting from in silico analyses were assessed for occurrence patterns in chosen taxa databases.
Combination of risk factors significant in univariate analyses were assessed and were selected in a stepwise algorithm, with variables entered and excluded for P > .025.025
Furthermore, the biomarkers used in the analyses were assessed at a single point in time at study baseline and may be susceptible to short-term variation, which could lead to bias toward the null.
Node support values in MP analyses were assessed using non-parametric bootstrapping for 1000 pseudo-replicates (10 random taxon addition sequence replicates per pseudo-replicate).
All variables examined in these analyses were assessed consistently and equivalently across the three cohorts.
Node support values in MP analyses were assessed using 100 jacknife replicates.
These process analyses are assessed weekly in an online questionnaire in the eight following weeks between pre-treatment and post-treatment.
The results from the immunohistochemical analyses of NHERF1 were assessed in relation to disease-free survival (DFS) and overall survival (OS).
Second, factors associated with subgroup analyses across PROGRESS-Plus were assessed in a systematic review of methods for assessing effects on health equity [ 25].
